Ceribell Reports First Quarter 2026 Financial Results
Ceribell reported Q1 2026 revenue of $26.5 million, a 29% increase from $20.5 million in the same period last year. The company ended the quarter with 680 total active accounts and achieved a gross margin of 87%. Ceribell initiated the commercial launch of its neonate and pediatric products following a successful pilot.
Key figures
- Revenue
- 26494000
- Guidance
- FY26 revenue $112M-$116M, representing growth of 26-30% over prior year
- Revenue Yoy
- 29%
- Net loss
- 19737000
- Gross margin
- 87%
- Gross profit
- 23122000
- Product revenue
- 20190000
- Operating expenses
- 43867000
- Adjusted ebitda loss
- 11170000
- Subscription revenue
- 6304000
- Marketable securities
- 95932000
- Cash and cash equivalents
- 45252000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.